Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
Annexon
ANNX
$835M
| $173K | ﹤0.01% |
33,366
+25,007
| +299% | +$137K |
|
3802
Codexis
CDXS
$151M
| $172K | ﹤0.01% |
36,992
+8,603
| +30% | +$47.2K |
|
3803
Vanguard Total World Stock ETF
VT
$77.1B
| $172K | ﹤0.01% |
+2,000
| New | +$171K |
|
3804
Ecovyst
ECVT
$1.32B
| $172K | ﹤0.01% |
19,442
+12,808
| +193% | +$118K |
|
3805
Suburban Propane Partners
SPH
$1.24B
| $172K | ﹤0.01% |
11,318
-6,966
| -38% | -$112K |
|
|
NWLI
3806
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $172K | ﹤0.01% |
611
+515
| +536% | +$110K |
|
3807
Vuzix
VUZI
$194M
| $172K | ﹤0.01% |
47,127
+44,612
| +1,774% | +$204K |
|
|
TBCP
3808
DELISTED
Thunder Bridge Capital Partners III Inc. Class A Common Stock
TBCP
| $171K | ﹤0.01% |
17,579
| – | – |
|
3809
York Water
YORW
$502M
| $171K | ﹤0.01% |
3,809
+3,173
| +499% | +$138K |
|
3810
Wheels Up
UP
$208M
| $171K | ﹤0.01% |
830
+183
| +28% | +$47.2K |
|
3811
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.7B
| $171K | ﹤0.01% |
+2,503
| New | +$172K |
|
3812
ProShares Short VIX Short-Term Futures ETF
SVXY
$201M
| $170K | ﹤0.01% |
5,810
| – | – |
|
3813
Stoke Therapeutics
STOK
$1.8B
| $170K | ﹤0.01% |
18,443
+7,880
| +75% | +$81.9K |
|
|
TPC
3814
Tutor Perini Cor
TPC
$4.41B
| $170K | ﹤0.01% |
22,520
+7,401
| +49% | +$52.4K |
|
3815
Dynagas LNG Partners
DLNG
$132M
| $170K | ﹤0.01% |
64,800
| – | – |
|
|
FPI
3816
Farmland Partners
FPI
$408M
| $170K | ﹤0.01% |
13,623
-951
| -7% | -$12.6K |
|
3817
Brookdale Senior Living
BKD
$3.49B
| $169K | ﹤0.01% |
61,968
+42,057
| +211% | +$157K |
|
3818
Nordic American Tanker
NAT
$1.38B
| $169K | ﹤0.01% |
55,232
+46,745
| +551% | +$151K |
|
|
AMNB
3819
DELISTED
American National Bankshares Inc
AMNB
| $169K | ﹤0.01% |
4,565
+2,311
| +103% | +$84.3K |
|
|
NAGE
3820
Niagen Bioscience
NAGE
$271M
| $168K | ﹤0.01% |
100,000
-193,769
| -66% | -$307K |
|
|
OKUR
3821
OnKure Therapeutics
OKUR
$154M
| $168K | ﹤0.01% |
7,193
| – | – |
|
|
TEAD
3822
Teads Holding Co
TEAD
$68.7M
| $168K | ﹤0.01% |
46,289
+1,724
| +4% | +$6.75K |
|
3823
NVE Corp
NVEC
$562M
| $168K | ﹤0.01% |
2,587
+2,302
| +808% | +$141K |
|
3824
Marcus Corp
MCS
$897M
| $167K | ﹤0.01% |
11,636
+5,339
| +85% | +$80.9K |
|
3825
MaxCyte
MXCT
$112M
| $167K | ﹤0.01% |
30,597
+19,377
| +173% | +$119K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.